Antimicrobial Resistance and Therapeutic Discovery Training Program
抗菌素耐药性和治疗发现培训计划
基本信息
- 批准号:8737434
- 负责人:
- 金额:$ 9.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
The challenge of drug-resistant microbes requires that a new generation of basic scientists be
broadly trained and educated in anti-infective research so that a cadre of investigators will be
available in the future to combat this global health problem. Coupled with the problem of
resistance, this need is especially acute given the reduced number of new, effective antibiotics
that have entered clinical practice in the past two decades. Thus, the objective of this new
training grant at Emory University is to provide high quality training to a select group of highly
motivated graduate students for careers as independent investigators in research on anti-
infectives. The program will select three PhD candidates yearly from four graduate programs
within the Graduate Division of Biological and Biomedical Sciences of Emory University for a
two year period of training in the areas of antimicrobial resistance and therapeutic discovery.
These graduate programs include faculty members from basic science and clinical departments
of the School of Medicine, Emory College of Arts and Sciences and the Centers for Disease
Control and Prevention (CDC). Educational training will consist of a course of study and
programmatic events in sub-disciplines that emphasize research and education in anti-infective
resistance and drug development; research training opportunities are provided in 25
laboratories with active research programs in these areas of research.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Maurice Shafer其他文献
William Maurice Shafer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Maurice Shafer', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10514632 - 财政年份:2020
- 资助金额:
$ 9.18万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10091811 - 财政年份:2020
- 资助金额:
$ 9.18万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10337023 - 财政年份:2020
- 资助金额:
$ 9.18万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
10646403 - 财政年份:2019
- 资助金额:
$ 9.18万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
10426304 - 财政年份:2019
- 资助金额:
$ 9.18万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
10201478 - 财政年份:2019
- 资助金额:
$ 9.18万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
9982208 - 财政年份:2019
- 资助金额:
$ 9.18万 - 项目类别:
Gonococci: Genetics of Resistance to PMN Proteins
淋球菌:PMN 蛋白抗性遗传学
- 批准号:
9040074 - 财政年份:2015
- 资助金额:
$ 9.18万 - 项目类别:
Antimicrobial Resistance and Therapeutic Discovery Training Program
抗菌素耐药性和治疗发现培训计划
- 批准号:
10019072 - 财政年份:2014
- 资助金额:
$ 9.18万 - 项目类别:
Antimicrobial Resistance and Therapeutic Discovery Training Program
抗菌素耐药性和治疗发现培训计划
- 批准号:
8852534 - 财政年份:2014
- 资助金额:
$ 9.18万 - 项目类别:
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Research Grant
Non invasive methods to accelerate the development of injectable therapeutic depots
非侵入性方法加速注射治疗储库的开发
- 批准号:
EP/Z532976/1 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Research Grant
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Research Grant
Collaborative Research: CPS: Medium: Automating Complex Therapeutic Loops with Conflicts in Medical Cyber-Physical Systems
合作研究:CPS:中:自动化医疗网络物理系统中存在冲突的复杂治疗循环
- 批准号:
2322534 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Standard Grant
Uncovering the antimicrobial and antibiotic potentiating mechanism of acesulfame-K and maximising its topical therapeutic potential.
揭示安赛蜜的抗菌和抗生素增强机制并最大限度地发挥其局部治疗潜力。
- 批准号:
MR/Y001354/1 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Research Grant
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Collaborative R&D
In vivo polymer synthesis for therapeutic application via glycosylated artificial metalloenzymes
通过糖基化人工金属酶进行体内聚合物合成用于治疗应用
- 批准号:
24K08629 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ヒトiPS細胞由来唾液腺幹細胞を用いた再生治療におけるTherapeutic time windowの同定
使用人类 iPS 细胞来源的唾液腺干细胞鉴定再生治疗的治疗时间窗
- 批准号:
24K12975 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 9.18万 - 项目类别:
Research Grant














{{item.name}}会员




